Navigation Links
Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
Date:6/2/2009

CARLSBAD, Calif., June 2 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the 29th Annual William Blair Growth Stock Conference at The Four Seasons Hotel in Chicago, Ill. on June 9 - 11, 2009.

Genoptix's President and CEO, Dr. Tina Nova, and Sam Riccitelli, EVP and COO, will present at the conference on Wednesday, June 10, 2009 beginning at approximately 9:20 a.m. CDT. They will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 30 minutes, which will be web cast live and made accessible through the "Investors" section of the Genoptix website at www.genoptix.com. The presentation will be followed by a 30-minute audience Q&A session. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix completed its initial public offering in November 2007 and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
2. Genoptix Reports Strong Growth for the First Quarter of 2009
3. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
4. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
5. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
6. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
7. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
8. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
9. Genoptix Announces the Addition of New Members to Board of Directors
10. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
11. Genoptix Reports Strong Financial Results for First Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... It’s no secret that aging ... to a host of health issues, including urinary incontinence. However, results published in ... that good overall muscle strength in older women, particularly in the abdominal and ...
(Date:2/27/2017)... ... , ... The threat of nuclear warfare has long plagued this world. In ... underground testing of nuclear weapons. Years later, when her co-workers began dying, Dot started ... Nuclear Testing,” Clayton exposes the critical decisions made by agencies involved in the nuclear ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... POUGHKEEPSIE, N. ... ) has disclosed that despite scientific studies, the Center for Disease Control ( CDC ... Lyme disease . Kenneth B. Liegner, M.D. has compiled into a single volume ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the top ... and genders. And the need for advanced services is growing. , Project WE ... care program, in collaboration with their non-profit partners in their fight against cancer and ...
(Date:2/26/2017)... New York, New York (PRWEB) , ... February ... ... of luxury baby products for wholesale distribution in North America, today announced it ... established online sites. The company, which prides itself on crafting quality and unique ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Israel and TAMPA, Fla. , Feb. ... emerging medical device company focused on developing cerebral ... applauds the members of the FDA,s Circulatory System ... their acknowledgement of the need for cerebral protection ... "The statements shared by this FDA panel ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
Breaking Medicine Technology: